1. Fairbrother JM, Gyles CL. Colibacillosis. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, editors. Disease of Swine. 2012;10th ed:p. 723–47.
2. WHO. Critically Important Antimicrobials for Human Medicine – 5th Rev. World Health Organization, Geneva. 2017.
3. Korea Animal Health Products Association (KAHPA). Animal health products handbook. KAHPA, Sungnam, Korea. 2001.
4. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990;34:1271–2.
5. Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 1996;40:879–85.
6. Tran JH, Jacoby GA. Mechanism of plasmid mediated quinolone resistance. PNAS 2002;99:5638–42.
7. Poirel L, Rodriguez-Martinez JM, Mammeri H, Liard A, Nordmann P. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 2005;49:3523–5.
8. Yamane K, Wachino JI, Suzuki S, Kimura K, Shibata N, Kato H, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 2007;51:3354–60.
9. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac (6’)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006;50:3953–5.
10. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006a;12:83–8.
11. Robicsek A, Jacoby GA. Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 2006b;6:629–40.
12. Kuo H, Chou C, Tu C, Gong S, Han C, Liao J, et al. Characterization of plasmid-mediated quinolone resistance by the qnrS gene in Escherichia coli isolated from healthy chickens and pigs. Veterinarni Medicina 2009;54:473–82.
13. Hu YS, Shin S, Park YH, Park KT. Prevalence and Mechanism of Fluoroquinolone Resistance in Escherichia coli Isolated from Swine Feces in Korea. J Food Prot 2017;80:1145–51.
14. Cheng P, Yang Y, Li F, Li X, Liu H, Fazilani SA, et al. The prevalence and mechanism of fluoroquinolone resistance in Escherichia coli isolated from swine farms in China. BMC Vet Res 2020;16:258.
15. CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals (VET01-S3). 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA. 2015.
16. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–81.
17. Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida K, Yoshida S. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother 2005;49:1660–1.
18. Bai H, Du JF, Hu M, Qi J, Cai YN, Niu WW, et al. Analysis of mechanisms of resistance and tolerance of Escherichia coli to enrofloxacin. Ann Microbiol 2012;62:293–8.
19. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003;47:2242–8.
20. Jiang Y, Zhou Z, Qian Y, Wei Z, Yu Y, Hu S, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6’)-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother 2008;61:1003–6.
21. Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S, et al. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of proteus mirabilis. Antimicrob Agents Chemother 2009;53:1892–7.
22. Cavaco LM, Hasman H, Xia S, Aarestrup FM. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 2009;53:603–8.
23. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 2007;51:3354–60.
24. Sandvang D, Aarestrup FM. Characterization of aminoglycoside resistance genes and class 1 integrons in porcine and bovine gentamicin-resistant Escherichia coli. Microb Drug Resist 2000;6:19–27.
25. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010;65 490–5.
26. Van TT, Chin J, Chapman T, Tran LT, Coloe PJ. Safety of raw meat and shellfish in Vietnam: an analysis of Escherichia coli isolations for antibiotic resistance and virulence genes. Int J Food Microbiol 2008;124:217–23.
27. Sandvang D, Aarestrup FM, Jensen LB. Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonellaenterica Typhimurium DT104. FEMS Microbiol Lett 1998;160:37–41.
28. Maynard C, Fairbrother JM, Bekal S, Sanschagrin F, Levesque RC, Brousseau R, et al. Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs. Antimicrob Agents Chemother 2003;47:3214–21.
29. Sengeløv G, Agersø Y, Halling-Sørensen B, Baloda SB, Andersen JS, Jensen LB. Bacterial antibiotic resistance levels in Danish farmland as a result of treatment with pig manure slurry. Environ Int 2003;28:587–95.
30. Ng LK, Mulvey MR, Martin I, Peters GA, Johnson W. Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella Serovar Typhimurium DT104. Antimicrob Agents Chemother 1999;43:3018–21.
31. Sáenz Y, Briñas L, Domínguez E, Ruiz J, Zarazaga M, Vila J, et al. Mechanisms of resistance in multiple-antibioticresistant Escherichia coli strains of human, animal, and food Origins. Antimicrob Agents Chemother 2004;48:3996–4001.
32. Do KH, Byun JW, Lee WK. Prevalence of O-serogroups, virulence genes, and F18 antigenic variants in Escherichia coli isolated from weaned piglets with diarrhea in Korea during 2008–2016. J Vet Sci 2019;20:43–50.
33. Johnson TJ, Wannemuehler YM, Johnson SJ, Logue CM, White DG, Doetkott C, et al. Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl Environ Microbiol 2007;73:1976–83.
34. Tamang MD, Nam HM, Jang GC, Kim SR, Chae MH, Jung SC, et al. Molecular characterization of extended-spectrum-b-lactamase-producing and plasmid-mediated AmpC b-lactamase-producing Escherichia coli isolated from stray dogs in South Korea. Antimicrob Agents Chemother 2012;56:2705–12.
35. Patel K, Goldman JL. Safety Concerns Surrounding Quinolone Use in Children. J Clin Pharmacol 2016;56:1060–75.
36. Threlfall EJ, Cheasty T, Graham A, Rowe B. High-level resistance to ciprofloxacin in Escherichia coli. Lancet 1997;349:403.
37. Li Y, Chen L, Wu X, Huo S.. Molecular characterization of multidrug-resistant avian pathogenic Escherichia coli isolated from septicemic broilers. Poult Sci 2015;94:601–11.
38. Mitra S, Mukherjee S, Naha S, Chattopadhyay P, Dutta S, Basu S. Evaluation of co-transfer of plasmid-mediated fluoroquinolone resistance genes and blaNDM gene in Enterobacteriaceae causing neonatal septicaemia. Antimicrob Resist Infect Control 2019;8:46.
39. Seo KW, Lee YJ. Prevalence and Characterization of Plasmid-Mediated Quinolone Resistance Determinants qnr and aac(6’)-Ib-cr in Ciprofloxacin-Resistant Escherichia coli Isolates from Commercial Layer in Korea. J Microbiol Biotechnol 2020;30:1180–3.
40. Gyles CL. Fimbriae of Escherichia coli. In: Gyles CL (ed.). Escherichia coli in Domestic Animals and Humans. pp. 399-436, CAB International, Wallingford. 1994.
41. Blanco M, Lazo L, Blanco JE, Dahbi G, Mora A, López C, et al. Serotypes, virulence genes, and PFGE patterns of enteropathogenic Escherichia coli isolated from Cuban pigs with diarrhea. Int Microbiol 2006;9:53–60.
42. Sato JPH, Takeuti KL, Andrade MR, Koerich PKV, Tagliari V, Bernardi ML, et al.. Virulence profiles of enterotoxigenic Escherichia coli isolated from piglets with post-weaning diarrhea and classification according to fecal consistency. Pesq Vet Bras 2016;36:253–7.
43. Noamani BN, Fairbrother JM, Gyles CL. Virulence genes of O149 enterotoxigenic Escherichia coli from outbreaks of postweaning diarrhea in pigs. Vet Microbiol 2003;97:87–101.
44. Chen X, Gao S, Jiao X, Liu XF. Prevalence of serogroups and virulence factors of Escherichia coli strains isolated from pigs with postweaning diarrhoea in eastern China. Vet Microbiol 2004;103:13–20.
45. Bolon MK. The newer fluoroquinolones. Med Clin N Am 2011;95:793–817.
46. Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, Eto F, et al. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia. Int J Antimicrob Agents 2010;35:387–91.
47. Yang J, Luo Y, Li J, Ma Y, Hu C, Jin S, et al. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants. J Antimicrob Chemother 2010;65:453–9.
48. Vila J, Ruiz J, Marco F, Barcelo A, Goñi P, Giralt E, et al. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother 1994;38:2477–9.
49. Domínguez E, Zarazaga M, Sáenz Y, Briñas L, Torres C. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain. Microb Drug Resist 2002;8:321–7.
50. Röderova M, Halova D, Papousek I, Dolejska M, Masarikova M, Hanulik V, et al. Characteristics of Quinolone Resistance in Escherichia coli Isolates from Humans, Animals, and the Environment in the Czech Republic. Front Microbiol 2017;7:2147.
51. Yu T, Jiang X, Fu K, Liu B, Xu D, Ji S, et al. Detection of extended-Spectrum beta-lactamase and plasmid-mediated quinolone resistance determinants in Escherichia coli isolates from retail meat in China. J Food Sci. 2015;80:M1039–M1043.
52. Pereira RV, Foditsch C, Siler JD, Dulièpre SC, Altier C, Garzon A, et al. Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin. Sci Rep 2020;10:19327.
53. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003;51:1109–17.
54. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis 2005;41:S120–S126.
55. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657–86.
56. Seo KW, Lee YJ. Detection of plasmid-mediated quinolone resistance genes in b-lactamase-producing Escherichia coli isolates from layer hens. Poult Sci 2019;98:1480–7.
57. Xue G, Li J, Feng Y, Xu W, Li S, Yan C, et al. High prevalence of plasmid-mediated quinolone resistance determinants in Escherichia coli and Klebsiella pneumoniae isolates from pediatric patients in China. Microb Drug Resist 2017;23:107–14.
58. Kang HY, Jeong YS, Oh JY, Tae SH, Choi CH, Moon DC, et al. Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J Antimicrob Chemother 2005;55:639–44.
59. Yang QE, Sun J, Li L, Deng H, Liu BT, Fang LX, et al. IncF plasmid diversity in multi-drug resistant Escherichia coli strains from animals in China. Front Microbiol 2015;6:964.
60. Fairbrother JM, Nadeau E, Gyles CL. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim Health Res Rev 2005;6:17–39.
61. Nguyen UV, Coddens A, Melkebeek V, Devriendt B, Goetstouwers T, Poucke MV, et al. High susceptibility prevalence for F4+ and F18+ Escherichia coli in Flemish pigs. Vet Microbiol 2017;202:52–7.
62. Zhang W, Zhao M, Ruesch L, Omot A, Francis D. Prevalence of virulence genes in Escherichia coli strains recently isolated from young pigs with diarrhea in the US. Vet Microbiol 2007;123:145–52.
63. Kusumoto M, Hikoda Y, Fujii Y, Murata M, Miyoshi H, Ogura Y, et al. Emergence of a multidrug-resistant Shiga toxin-producing enterotoxigenic Escherichia coli lineage in diseased swine in Japan. J Clin Microbiol 2016;54:1074–81.
64. Luppi A, Gibellini M, Gin T, Vangroenweghe F, Vandenbroucke V, Bauerfeind R, et al. Prevalence of virulence factors in enterotoxigenic Escherichia coli isolated from pigs with post-weaning diarrhoea in Europe. Porcine Health Manag 2016;2:20.
65. Byun JW, Jung BY, Kim HY, Fairbrother JM, Lee MH, Lee WK. O-serogroups, virulence genes of pathogenic Escherichia coli and pulsed-field gel electrophoresis (PFGE) patterns of O149 isolates from diarrhoeic piglets in Korea. Vet Med (Praha) 2013;58:468–76.
66. Leclerc S, Boerlin P, Gyles C, Dubreuil JD, Mourez M, Fairbrother JM, et al. Paa, originally identified in attaching and effacing Escherichia coli, is also associated with enterotoxigenic E. coli. Res Microbiol 2007;158:97–104.